Biomarkers of Irritant-Induced and Allergic Asthma
NCT02740543
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Fluticasone propionate HFA 220
Sponsor
NYU Langone Health